Cytek Biosciences, Inc.CTKBNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+16.9%
5Y CAGR+34.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+16.9%/yr
Annual compound
5Y CAGR
+34.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $108.38M | +17.5% |
| 2024 | $92.23M | -1.0% |
| 2023 | $93.12M | +37.1% |
| 2022 | $67.92M | +49.1% |
| 2021 | $45.55M | +87.0% |
| 2020 | $24.36M | +43.5% |
| 2019 | $16.98M | - |